NCT07387679Completed
Myo-inositol Versus Metformin in Patients With Polycystic Ovarian Syndrome to Treat Obesity
Comparison of Myo-inositol Versus Metformin for Treating Obesity in Patients With Polycystic Ovarian Syndrome
Source: ClinicalTrials.gov · Last updated 4 Feb 2026
Brief summary (registry, in English)
There are considerable gaps in the comparative effectiveness and tolerability of myo-inositol and metformin for treating obesity in patients with polycystic ovarian syndrome (PCOS). The current study aimed to give insights comparing myo-inositol versus metformin for treating obesity in patients with PCOS.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 26 Jan 2026
- Start date
- 29 Nov 2024
- Primary completion date
- 28 May 2025
- Lead sponsor
- Muhammad Aamir Latif
- Diseases
- Obesity
- NCT number
- NCT07387679
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 29 Nov 2024 to the primary completion date, 28 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Adrenal hyperplasia or Cushing's syndrome (on history \& medical record review)
Other
- Women with hyperprolactinemia or hypothyroidism (on history \& medical record review)
Who the study is looking for
- Females aged 18-45 years
- Diagnosed case of PCOS for more than 6 months of duration
Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bahwal Victoria Hospital Coordinator of this site? Confirm its status | Bahawalpur | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.